John has over 2 decades of experience co-founding and building hard technology-based companies leading from inception to exit. He holds an economics degree from Duke University and Immunology Ph.D. from the University of Chicago.

He is a former Investment associate of ARCH Venture partners (Hard tech industries); Founder and CEO of Ancora Pharmaceuticals which was acquired by Corden Pharma in 2012.